The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
The U.S. Food and Drug Administration has authorized booster shots of the Moderna and Pfizer COVID-19 vaccines for all adults ages 18 and older. On Friday, the FDA announced it had amended the ...
Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results